SEC EDGAR filings, ownership reports, and insider transactions for Telix Pharmaceuticals Ltd.
Recent SEC filings for Telix Pharmaceuticals Ltd including 6-K, 20-F, SCHEDULE 13G and more.
| Form type | Document | Filing | Description | Filing date | Reporting date | File number(s) |
|---|---|---|---|---|---|---|
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 20 Jan 2026 | 19 Jan 2026 | 001-42128 |
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 12 Jan 2026 | 12 Jan 2026 | 001-42128 |
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 22 Dec 2025 | 21 Dec 2025 | 001-42128 |
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 17 Dec 2025 | 17 Dec 2025 | 001-42128 |
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 08 Dec 2025 | 07 Dec 2025 | 001-42128 |
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 14 Oct 2025 | 14 Oct 2025 | 001-42128 |
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 23 Sep 2025 | 22 Sep 2025 | 001-42128 |
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 09 Sep 2025 | 08 Sep 2025 | 001-42128 |
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 28 Aug 2025 | 04 Aug 2025 | 001-42128 |
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 21 Aug 2025 | 20 Aug 2025 | 001-42128 |
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 22 Jul 2025 | 22 Jul 2025 | 001-42128 |
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 09 Jul 2025 | 08 Jul 2025 | 001-42128 |
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 11 Jun 2025 | 11 Jun 2025 | 001-42128 |
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 21 May 2025 | 20 May 2025 | 001-42128 |
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 29 Apr 2025 | 27 Apr 2025 | 001-42128 |
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 22 Apr 2025 | 22 Apr 2025 | 001-42128 |
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 17 Apr 2025 | 16 Apr 2025 | 001-42128 |
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 17 Apr 2025 | 15 Apr 2025 | 001-42128 |
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 08 Apr 2025 | 06 Apr 2025 | 001-42128 |
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 04 Apr 2025 | 03 Apr 2025 | 001-42128 |
| 6-K | Open 6-K document | View SEC filing for 6-K | 21 Mar 2025 | 20 Mar 2025 | 001-42128 | |
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 18 Mar 2025 | 17 Mar 2025 | 001-42128 |
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 12 Mar 2025 | 11 Mar 2025 | 001-42128 |
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 27 Feb 2025 | 25 Feb 2025 | 001-42128 |
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 26 Feb 2025 | 25 Feb 2025 | 001-42128 |
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 25 Feb 2025 | 25 Feb 2025 | 001-42128 |
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 24 Feb 2025 | 24 Feb 2025 | 001-42128 |
| 20-F | Open 20-F document | Open XBRL data | View SEC filing for 20-F | 20-F | 24 Feb 2025 | 31 Dec 2024 | 001-42128 |
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 21 Feb 2025 | 20 Feb 2025 | 001-42128 |
| SCHEDULE 13G | Open SCHEDULE 13G document | View SEC filing for SCHEDULE 13G | 14 Feb 2025 | 005-94874 | ||
| SCHEDULE 13G | Open SCHEDULE 13G document | View SEC filing for SCHEDULE 13G | 14 Feb 2025 | 005-94874 | ||
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 13 Feb 2025 | 12 Feb 2025 | 001-42128 |
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 31 Jan 2025 | 30 Jan 2025 | 001-42128 |
| 6-K | Open 6-K document | View SEC filing for 6-K | 27 Jan 2025 | 27 Jan 2025 | 001-42128 | |
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 17 Jan 2025 | 16 Jan 2025 | 001-42128 |
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 13 Jan 2025 | 13 Jan 2025 | 001-42128 |
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 13 Jan 2025 | 12 Jan 2025 | 001-42128 |
| 6-K | Open 6-K document | View SEC filing for 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 30 Dec 2024 | 29 Dec 2024 | 001-42128 |
| S-8 | Open S-8 document | View SEC filing for S-8 | S-8 | 19 Dec 2024 | 333-283917 | |
| SEC STAFF LETTER | Open SEC STAFF LETTER document | View SEC filing for SEC STAFF LETTER | 21 Nov 2024 | |||
| 6-K | Open 6-K document | View SEC filing for 6-K | 6-K | 19 Nov 2024 | 19 Nov 2024 | 001-42128 |
| 6-K | Open 6-K document | View SEC filing for 6-K | 6-K | 14 Nov 2024 | 12 Nov 2024 | 001-42128 |
| EFFECT | Open EFFECT document | View SEC filing for EFFECT | 12 Nov 2024 | 333-282705 | ||
| SEC STAFF ACTION | Open SEC STAFF ACTION document | View SEC filing for SEC STAFF ACTION | 12 Nov 2024 | |||
| CERT | Open CERT document | View SEC filing for CERT | 12 Nov 2024 | 001-42128 | ||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 12 Nov 2024 | |||
| 20FR12B/A | Open 20FR12B/A document | View SEC filing for 20FR12B/A | 20FR12B/A | 30 Oct 2024 | 001-42128 | |
| SEC STAFF LETTER | Open SEC STAFF LETTER document | View SEC filing for SEC STAFF LETTER | 28 Oct 2024 | |||
| F-6 | Open F-6 document | View SEC filing for F-6 | 17 Oct 2024 | 333-282705 | ||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 17 Oct 2024 | |||
| 20FR12B | Open 20FR12B document | View SEC filing for 20FR12B | 20FR12B | 17 Oct 2024 | 001-42128 | |
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 10 Oct 2024 | 377-07439 | ||
| DRS | Open DRS document | View SEC filing for DRS | 13 Sep 2024 | 377-07439 | ||
| RW | Open RW document | View SEC filing for RW | RW | 14 Jun 2024 | 333-279808 | |
| RW | Open RW document | View SEC filing for RW | RW | 14 Jun 2024 | 333-279471 | |
| 8-A12B | Open 8-A12B document | View SEC filing for 8-A12B | 8-A12B | 10 Jun 2024 | 001-42128 | |
| F-1/A | Open F-1/A document | View SEC filing for F-1/A | F-1/A | 05 Jun 2024 | 333-279471 | |
| F-6 | Open F-6 document | View SEC filing for F-6 | 30 May 2024 | 333-279808 | ||
| F-1 | Open F-1 document | View SEC filing for F-1 | F-1 | 17 May 2024 | 333-279471 | |
| DRS/A | Open DRS/A document | View SEC filing for DRS/A | 09 May 2024 | 377-07070 | ||
| DRS/A | Open DRS/A document | View SEC filing for DRS/A | 15 Apr 2024 | 377-07070 | ||
| DRS/A | Open DRS/A document | View SEC filing for DRS/A | 15 Mar 2024 | 377-07070 | ||
| DRS/A | Open DRS/A document | View SEC filing for DRS/A | 02 Feb 2024 | 377-07070 | ||
| DRS | Open DRS document | View SEC filing for DRS | 25 Jan 2024 | 377-07070 |
Telix Pharmaceuticals Ltd files with the SEC under CIK 0002007191. This page aggregates EDGAR filings and related ownership activity.
Industry: Pharmaceutical Preparations.